470 likes | 573 Views
HEART TRANSPLANTATION. Pediatric Recipients. AGE DISTRIBUTION OF PEDIATRIC HEART RECIPIENTS (1982-2001). AGE DISTRIBUTION FOR DONORS OF PEDIATRIC HEART RECIPIENTS (1982-2001). 385. 378. 372. 365. 363. 364. 349. 350. 356. 326. 340. 319. 254. 193. 130. 109. 75. 42. 11. 9.
E N D
HEART TRANSPLANTATION Pediatric Recipients
AGE DISTRIBUTION FOR DONORS OF PEDIATRIC HEART RECIPIENTS(1982-2001)
385 378 372 365 363 364 349 350 356 326 340 319 254 193 130 109 75 42 11 9 AGE DISTRIBUTION OF PEDIATRIC HEART RECIPIENTSBy Year of Transplant Number of Transplants * Numbers may be low due to delayed reporting.
NUMBER OF CENTERS REPORTING PEDIATRIC HEART TRANSPLANTS * Numbers may be low due to delayed reporting
DIAGNOSIS IN PEDIATRIC HEART TRANSPLANT RECIPIENTS (Age: < 1 Year)
DIAGNOSIS IN PEDIATRIC HEART TRANSPLANT RECIPIENTS(Age: 1-10 Years)
DIAGNOSIS IN PEDIATRIC HEART TRANSPLANT RECIPIENTS(Age: 11-17 Years)
PEDIATRIC HEART TRANSPLANTATIONActuarial Survival (1982-2001) <1 year vs. 1-10 years: p = 0.0005 <1 year vs. 11-17 years: p = 0.001
PEDIATRIC HEART TRANSPLANTATIONConditional Actuarial Survival(1982-2001) Both comparisons with 11-17 years significant at p < 0.0001
PEDIATRIC HEART TRANSPLANTATIONConditional Actuarial Survival for Recent Era (1998-2001) Comparison of <1 vs. 11-17 years significant at p = 0.01
PEDIATRIC HEART TRANSPLANTATIONActuarial Survival by Era (1982-2001) Survival (%) All comparisons with 1998-2001 are significant at p < 0.0001 Comparison of 1982-1987 vs. 1988-1992 was significant at p = 0.003 Comparison of 1982-1987 vs. 1993-1997 was significant at p < 0.0001
PEDIATRIC HEART TRANSPLANTATION Actuarial Survival by Age GroupFor Diagnosis = Cardiomyopathy(1988-2001) Survival (%) No comparisons were statistically significant.
PEDIATRIC HEART TRANSPLANTATION Actuarial Survival By Age GroupFor Diagnosis = Congenital Disease(1988-2001) Survival (%) Comparison of <1 vs. 11-17 was significant at p = 0.01
PEDIATRIC HEART TRANSPLANTS (1996-2001)Risk Factors For 1 Year MortalityIn Descending Order of Magnitude N=1,554
PEDIATRIC HEART TRANSPLANTS (1996-2001)Risk Factors for 1 Year MortalityContinuous Factors N=1,554
PEDIATRIC HEART TRANSPLANTS (1996-2001) Factors Not Significant for 1 Year Mortality
PEDIATRIC HEART TRANSPLANTS (April 1994 - December 1996)Risk Factors For 5 Year MortalityIn Descending Order of Magnitude N=937
PEDIATRIC HEART TRANSPLANTS (April 1994 - December 1996)Risk Factors For 5 Year MortalityContinuous Factors N=937
PEDIATRIC HEART TRANSPLANTS(April 1994 - December 1996)Factors Not Significant for 5 Year Mortality
PEDIATRIC HEART TRANSPLANTS (April 1994 - December 1996)Risk Factors for 5 Year Mortality Conditional on Survival to 1 YearIn Descending Order of Magnitude N=728
PEDIATRIC HEART RECIPIENTS Functional Status (April 1994-December 2001)
PEDIATRIC HEART RECIPIENTS Rehospitalization Post-transplant(April 1994 - December 2001)
PEDIATRIC HEART RECIPIENTSInduction ImmunosuppressionFor follow-ups between October 1999 and December 2001
PEDIATRIC HEART RECIPIENTSMaintenance Immunosuppression at Any Time During Follow-up PeriodFor follow-ups between October 1999 and December 2001
PEDIATRIC HEART RECIPIENTSMaintenance Immunosuppression at Time of Follow-upFor follow-ups between October 1999 and December 2001
PEDIATRIC HEART RECIPIENTSMaintenance Immunosuppression at Time of Follow-upFor follow-ups between October 1999 and December 2001 1 Year Follow-up (N=429) 5 Year Follow-up (N = 303)
PEDIATRIC HEART RECIPIENTSMaintenance Immunosuppression at Time of Follow-upFor follow-ups between October 1999 and December 2001
POST-HEART TRANSPLANT MORBIDITY FOR PEDIATRICSCumulative Incidence for Survivors(April 1994-December 2001)
Freedom from CAV For Pediatric Heart Recipients(April 1994-December 2000)
Freedom from Renal Dysfunction*For Pediatric Heart Recipients(April 1994-December 2000) * Renal dysfunction = Creatinine > 2.5 mg/dl, dialysis or renal transplant
MALIGNANCY POST-HEART TRANSPLANTATION FOR PEDIATRICSCumulative Incidence for Survivors(April 1994-December 2001)
Freedom from MalignancyFor Pediatric Heart Recipients(April 1994-December 2000)
PEDIATRIC HEART TRANSPLANTATIONActuarial Survival Based on Prednisone Use p = 0.005
PEDIATRIC HEART TRANSPLANTATIONActuarial Survival Based on Rejection within 1st Year P = 0.09
PEDIATRIC HEART RECIPIENTSRelationship of Prednisone Use and CADTransplants: April 1994 – December 1999 p = 0.4 p = 0.06
PEDIATRIC HEART RECIPIENTSRelationship of Rejection and CADTransplants: April 1994 – December 1999 p = 0.02 p = 0.09
PEDIATRIC HEART RECIPIENTS Incidence of Hypertension between 1 and 3 Years
PEDIATRIC HEART RECIPIENTS Incidence of Hypertension by 3 Years
PEDIATRIC HEART RECIPIENTSGrowth Following Transplantation: HeightStratified by Prednisone Use at Discharge and at 1 Year
PEDIATRIC HEART RECIPIENTSGrowth Following Transplantation: WeightStratified by Prednisone Use at Discharge and at 1 Year
PEDIATRIC HEART TRANSPLANT RECIPIENTS: Cause of Death(1982-2001) Cause of Death (%) Timing of Death
PEDIATRIC HEART TRANSPLANTS RECIPIENTS: CAUSE OF DEATH BY ERA: Deaths in 0-30 Days
PEDIATRIC HEART TRANSPLANTS RECIPIENTS: CAUSE OF DEATH BY ERA: Deaths in 31 Days - 1 Year
PEDIATRIC HEART TRANSPLANTS RECIPIENTS: CAUSE OF DEATH BY ERA: Deaths in >1 Year - 3 Years
PEDIATRIC HEART TRANSPLANTS RECIPIENTS:CAUSE OF DEATH BY ERA: Deaths in >3 Years - 5 Years